Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 120 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.
Creasallis is the creative antibody solutions company looking to alleviate bottlenecks in antibody therapies. The debut technology, CreaTap is a technology to improve the penetration of cancer based antibody drugs into the tumour. Creasallis is a start up from the Accelerate@ Babraham 2021 cohort and was founded by the CEO Zahra Jawad.
Creative Biolabs is a leading provider of custom antibody development and production services with extensive expertise. The company offers monoclonal antibody generation in mice, rats, humans, monkeys, rabbits, chickens, dogs, llamas, and camels using hybridoma and antibody library technologies such as phage, bacterial, and yeast display. Its expertise includes antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. Additionally, it provides cost-effective OEM services for large-scale antibody manufacturing, including bacterial expression of scFv, diabody, tandem scFv, mini-antibody, and Fab, as well as mammalian expression of mini-antibody, chimeric IgG, and IgG.
Creative Places is a property consultancy helping clients to create business environments that enhance innovation and enterprise. We work throughout the UK and, as well as acting for businesses, we work for many leading hospitals, universities and government establishments.
Software for calculating and comparing molecular field characteristics of chemical compounds and consultancy services enabling companies to outsource computational chemistry work to achieve high value, on-demand expertise, particularly in areas of library design, virtual screening, scaffold hopping, lead optimisation and patent analysis. Cresset’s field technology uses surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. This provides a smarter, structure independent way of hit-finding, lead switching and lead optimisation in drug discovery and other chemistry-based research projects.
Cushman & Wakefield are a global real estate service provider with local expertise around the world. The company have specialists advising in the Life Sciences and technology sector advising companies in how and where to set up new facilities, handling strategy, negotiation, analysis and implementation for companies from start up through to big pharma.
CW is the leading international community for companies involved in the research, development and application of wireless and mobile, internet, semiconductor and software technologies.
With an active community of over 1000 technology companies ranging from major network operators and device manufacturers to innovative start-ups and universities, CW stimulates debate and collaboration, harnesses and shares knowledge, and helps to build connections between academia and industry. Join the CW community at https://www.cambridgewireless.co.uk
With an active community of over 1000 technology companies ranging from major network operators and device manufacturers to innovative start-ups and universities, CW stimulates debate and collaboration, harnesses and shares knowledge, and helps to build connections between academia and industry. Join the CW community at https://www.cambridgewireless.co.uk
Cytocell Ltd is a leading European developer and manufacturer of FISH probes for use in both routine cytogenetics and in the analysis and classification of cancers. Recently, the company has focused on developing products for oncology and now has a catalogue of some 350 products for cytogenetics, haematology and solid tumour analysis as well as developing custom FISH probes for customers with specific interests under the myProbes® brand. Cytocell’s products are available through a well established distributor network, covering more than 60 countries worldwide. Cytocell’s FISH probe service is currently proving to be invaluable to cancer researchers and clinicians worldwide.
D Young & Co is a leading intellectual property firm. We are proactive, insightful and international and our Life Science team is one of the leading IP practices in Europe. Clients choose D Young & Co for IP services confident in the knowledge, experience and dedication that has characterised our work throughout our firm’s history.
No data available